This opportunity is now closed.

Funded PhD Opportunity

Novel fatty acid receptors in islet cells as therapeutic targets for diabetes

Subject: Biomedical Sciences


Summary

The prevalence of type 2 diabetes has risen dramatically during recent decades and there is an urgent need to develop new approaches for disease treatment. Approaches to counteract defective insulin secretion and low beta cell mass in diabetes are key in developing therapeutic strategies. In recent years, therapies that target the actions of glucagon-like peptide-1 (GLP-1) which stimulate insulin secretion through activation of beta cell G-protein coupled receptors (GPCRs) have been successful. This has resulted in substantial interest in targeting other islet GPCRs for diabetic therapies [1-3].

There is an increasing need for new pharmaceutical therapies which preserve beta cell function, decrease weight gain and represent a low risk of hypoglycaemia in diabetes treatment. GPCRs have become the target of approximately 50% of recently developed pharmaceutical agents. Our published work demonstrates that GPCRs activated by endogenous and synthetic agonists in islets, are co-localised with insulin on islet beta cells, and exhibit insulinotropic and glucose lowering activity [4-8]. This research project represents an important step in the validation of these islet targets for improved diabetes treatment and care. This studentship will investigate the biological activation of two GPCRs as therapeutic targets for type 2 diabetes treatment. The multi-faceted research expertise and vision of the Diabetes Research Group coupled with a highly productive team of internationally recognized scientists offers a strong foundation for studentship training.

This research project provides an excellent research training opportunity and represents an important step in the validation of GPCR targets for improved diabetes treatment. The specific project aims:

(i)To determine the functional role of novel GPCRs in the regulation of insulin and glucagon secretion using the clonal pancreatic beta cell line and alpha glucagon secreting cell line; (Milestones: 0-6 months)

(ii)To investigate the mechanism of action and intracellular signalling events activated by islet GPCRs and determine their role in the regulation of cellular proliferation and islet cell mass; (Milestones: 0-12 months)

(iii)To explore the response to activation of GPCR receptors expressed in intestinal cells using GLUTag (GLP-1 secreting) cell line, pGIPneo STC-1 (GIP secreting) cell line, and primary intestinal tissues; (Milestones: 12-24 months)

(iv)To investigate gene knockout of GPCRs in BRIN-BD11 cells using CRISPR/Cas9 (Clustered regularly interspaced short palindromic repeats) gene editing tool; (Milestones 14-24 months)

(v)To determine the effects of GPCR agonist monotherapy and combination therapies with other established diabetic therapies such as dipeptidyl-peptidase-IV (DPP-IV) inhibitors in vivo (Milestones 24-36 months).

References:

1.Moran BM, Flatt PR, McKillop AM. (2016) Acta Diabetol. 53(2):177-88

2.Moran BM, McKillop AM, O'Harte FPM. (2016). Curr Opin Pharmacol. 31:57-62.

3.Ahren B. (2009). Nature Reviews 8: 369-385.

4.McKillop AM, Moran BM, Abdel-Wahab YH, Flatt PR. (2013). Br J Pharmacol 170(5):978-90.

5.McKillop AM, Moran BM, Abdel-Wahab YH, Gormley NM, Flatt PR. (2016) Diabetologia 59(12):2674-2685.

6.Moran BM, Abdel-Wahab YH, Flatt PR, McKillop AM. (2014). Biological Chemistry 395:453-64.

7.Moran BM, Abdel-Wahab YH, Flatt PR, McKillop AM. (2014). Diabetes Obes Metab. 16:1128-39.

8.Moran BM, Abdel-Wahab YH, Vasu S, Flatt PR, McKillop AM. (2016) Acta Diabetol 53(2):279-93.


Essential criteria

  • Upper Second Class Honours (2:1) Degree or equivalent from a UK institution (or overseas award deemed to be equivalent via UK NARIC)
  • Sound understanding of subject area as evidenced by a comprehensive research proposal
  • A comprehensive and articulate personal statement

Desirable Criteria

If the University receives a large number of applicants for the project, the following desirable criteria may be applied to shortlist applicants for interview.

  • First Class Honours (1st) Degree
  • Completion of Masters at a level equivalent to commendation or distinction at Ulster
  • Research project completion within taught Masters degree or MRES
  • Experience using research methods or other approaches relevant to the subject domain
  • Work experience relevant to the proposed project
  • Publications - peer-reviewed
  • Experience of presentation of research findings

Funding

    Vice Chancellors Research Scholarships (VCRS)

    The scholarships will cover tuition fees and a maintenance award of £14,777 per annum for three years (subject to satisfactory academic performance). Applications are invited from UK, European Union and overseas students.

    DFE

    The scholarship will cover tuition fees at the Home rate and a maintenance allowance of £ 14,777 per annum for three years. EU applicants will only be eligible for the fees component of the studentship (no maintenance award is provided).  For Non EU nationals the candidate must be "settled" in the UK.


Other information


The Doctoral College at Ulster University


Reviews

My experience has been great and the people that I have worked with have been amazing

Kieran O'Donnell - 3D printing of biological cells for tissue engineering applications

Watch Video  

Completing the MRes provided me with a lot of different skills, particularly in research methods and lab skills.

Michelle Clements Clements - MRes - Life and Health Sciences

Watch Video  

Throughout my PhD I’ve been provided with continuous support and guidance by my supervisors and the staff at the University.I’ve also received many opportunities to further enhance my professional development in the form of teaching experience and presenting my work at conferences which will aid in my pursuit of a career in academia or industry.

William Crowe


Key dates

Submission deadline
Monday 19 February 2018

Interview Date
6, 7 and 8 March 2018


Contact supervisor

Professor Aine McKillop


Other supervisors


Applying

Apply Online

Related Funded Opportunities in: Biomedical Sciences ,

The production of rhamnolipid biosurfactant by Pseudomonas aeruginosa growing in biofilms.

Closing date:
Sunday 1 September 2019
Subject:
Biomedical Sciences

 View Details

The regulation of rhamnolipid biosynthesis in Burkholderia thailandensis.

Closing date:
Sunday 1 September 2019
Subject:
Biomedical Sciences

 View Details

Diabetes

Subject:
Biomedical Sciences

 View Details

Genomic Medicine

Subject:
Biomedical Sciences

 View Details

Stratified Medicine

Subject:
Biomedical Sciences

 View Details

Novel amphibian skin peptide-analogues for the treatment of type-2 diabetes

Closing date:
Wednesday 18 September 2019
Subject:
Biomedical Sciences

 View Details

Using the Eye to Predict risk for Cardiovascular disease- The Living Lab

Closing date:
Friday 27 September 2019
Subject:
Biomedical Sciences|Engineering

 View Details

The design and analysis of a novel photo-activated antimicrobial system

Closing date:
Sunday 1 September 2019
Subject:
Biomedical Sciences

 View Details

Optometry and Vision Science

Subject:
Biomedical Sciences

 View Details

MRes in Biomedical Sciences

Subject:
Biomedical Sciences

 View Details

Molecular Pathology of Glaucoma

Closing date:
Wednesday 1 January 2020
Subject:
Biomedical Sciences

 View Details